A genome-wide analysis of lentivector integration sites using targeted sequence capture and next generation sequencing technology.

One application of next-generation sequencing (NGS) is the targeted resequencing of interested genes which has not been used in viral integration site analysis of gene therapy applications. Here, we combined targeted sequence capture array and next generation sequencing to address the whole genome profiling of viral integration sites. Human 293T and K562 cells were transduced with a HIV-1 derived vector. A custom made DNA probe sets targeted pLVTHM vector used to capture lentiviral vector/human genome junctions. The captured DNA was sequenced using GS FLX platform. Seven thousand four hundred and eighty four human genome sequences flanking the long terminal repeats (LTR) of pLVTHM fragment sequences matched with an identity of at least 98% and minimum 50 bp criteria in both cells. In total, 203 unique integration sites were identified. The integrations in both cell lines were totally distant from the CpG islands and from the transcription start sites and preferentially located in introns. A comparison between the two cell lines showed that the lentiviral-transduced DNA does not have the same preferred regions in the two different cell lines.

[1]  Hanno Glimm,et al.  High-resolution insertion-site analysis by linear amplification–mediated PCR (LAM-PCR) , 2007, Nature Methods.

[2]  F. Bushman,et al.  DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer , 2008, Nucleic acids research.

[3]  J. Silver,et al.  Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus , 1989, Journal of virology.

[4]  F. Bushman,et al.  Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences , 2004, PLoS biology.

[5]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[6]  A. Jauch,et al.  Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. , 2003, Blood.

[7]  M. Lovett,et al.  Direct selection: a method for the isolation of cDNAs encoded by large genomic regions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. Bushman,et al.  HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. , 2007, Genome research.

[9]  F. Graham,et al.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.

[10]  Shoshannah L. Roth,et al.  A method to sequence and quantify DNA integration for monitoring outcome in gene therapy , 2011, Nucleic acids research.

[11]  F. Bushman,et al.  Retroviral DNA integration: HIV and the role of LEDGF/p75. , 2006, Trends in genetics : TIG.

[12]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[13]  Rafael J. Yáñez-Muñoz,et al.  Lentiviral vector integration profiles differ in rodent postmitotic tissues. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  D. Covas,et al.  Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells , 2010, Biotechnology Letters.

[15]  A. Stewart,et al.  Retrovirus-mediated gene transfer into human hematopoietic stem cells , 1998, Journal of Molecular Medicine.

[16]  M. Wiznerowicz,et al.  Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA Interference , 2003, Journal of Virology.

[17]  Michael E Zwick,et al.  Combining Microarray‐based Genomic Selection (MGS) with the Illumina Genome Analyzer Platform to Sequence Diploid Target Regions , 2009, Annals of human genetics.

[18]  C. von Kalle,et al.  Detection of retroviral integration sites by linear amplification-mediated PCR and tracking of individual integration clones in different samples. , 2009, Methods in molecular biology.

[19]  F. Graham,et al.  Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. , 1997, Virology.

[20]  G Opelz,et al.  QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis , 2009, Gene Therapy.

[21]  F. Deist,et al.  Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. , 2000, Science.

[22]  A. MacNeil,et al.  Genomic Sites of Human Immunodeficiency Virus Type 2 (HIV-2) Integration: Similarities to HIV-1 In Vitro and Possible Differences In Vivo , 2006, Journal of Virology.

[23]  H. Allgayer,et al.  Analysis of self-inactivating lentiviral vector integration sites and flanking gene expression in human peripheral blood progenitor cells after alkylator chemotherapy. , 2010, Human gene therapy.

[24]  F. Bushman,et al.  Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemia. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  Christof von Kalle,et al.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. , 2003, The New England journal of medicine.

[26]  F. Bushman,et al.  Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting , 2007, PloS one.

[27]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[28]  Jon R. Armstrong,et al.  Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue. , 2011, The Journal of molecular diagnostics : JMD.

[29]  I. Davidson,et al.  Development of the hot spot-combined PCR assay for detection of retroviral insertions into Marek's disease virus. , 1999, Journal of virological methods.

[30]  Torsten Schaller,et al.  HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2 , 2011, PLoS pathogens.